Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.9.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.55SYoung-STATACATGTCTCTGGGACCA20452176321782F-18860.4Singapore
BA.2.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XWSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
JN.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDJSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.36.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-12905.4Singapore
BA.2.86.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
AY.58 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CP.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBGSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.98 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
XDTSYoung-STATACATGTCTCTGGGACCA20452176321782F-12905.4Singapore
HK.21SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.617.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.109 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.4.2.2 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.4.2.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.4.8 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.617.1 (Kappa)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.4.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.46.5 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDFSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.575.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
GK.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.620SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDMSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.2.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-12306.8Singapore
LV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HK.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GE.1.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
JN.2.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JC.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used